October 2026
Scent & Care | Corporate | Financial October 13, 2026
Symrise opens new Scent Creative Center in Singapore to accelerate growth in Asia
– Consumer-centric hub brings customers, perfumers and experts together for faster co-creation
– Global Skin Cleansing Center of Excellence strengthens category expertise and elevate sharing of best practices
– Creative Center advances ONE Symrise ecosystem and long-term commitment to Singapore & Asia
September 2026
Scent & Care | Corporate | Financial September 22, 2026
Symrise strengthens natural fragrance ecosystem with new Lautier 1795 site in Grasse
– Strategic investment expands Symrise capabilities for premium natural fragrance ingredients
– Connects sourcing, transformation, innovation and production in the heart of the Grasse ecosystem
– Advances ONE Symrise by linking specialist local expertise with the Group’s global fragrance capabilities
Scent & Care | Corporate | Financial September 16, 2026
Symrise completes acquisition of Floral Concept, strengthening its position in Premium Naturals
– Completion reinforces Symrise’s Premium Naturals position in fragrance
– Floral Concept joins Maison Lautier 1795 in a Naturals cluster in Grasse
– Combined expertise spans sourcing, transformation and fragrance creation
– Acquisition supports ONE Symrise and active portfolio development
Scent & Care | Corporate | Financial September 1, 2026
Symrise signs agreement to divest its Terpene Ingredients business to Mutares SE & Co. KGaA
— Positions AmeriTerpenes LLC for long-term growth under Mutares' ownership
— Advances the ONE Symrise strategy through continued portfolio management
— Secures long-term supply, customer service, and commercial partnership between Symrise and AmeriTerpenes
July 2026
Corporate | Financial July 30, 2026
Symrise reports solid H1 2026 performance with accelerating growth momentum in Q2
– Organic sales growth accelerated to 4.5% in Q2 2026 (2.0% in H1 2026)
– Adjusted EBITDA of €553 million and 21.8% adjusted EBITDA margin
– Adjusted Business Free Cash Flow margin up 450 bps to 13.7% of sales
– Planned acquisition of Floral Concept will strengthen position in Premium Naturals
– Full year 2026 outlook reaffirmed
Scent & Care | Corporate | Financial July 23, 2026
Symrise signs a put option agreement to acquire Floral Concept
- Contemplated acquisition accelerates Symrise towards a leading position in Premium Naturals and enhances its offering for Fragrance customers
- Creates a distinctive, best-in-class Naturals cluster in Pays de Grasse by bringing together Floral Concept and Maison Lautier within its Fragrance division
- Supports Symrise’s ONE Symrise strategy to drive for profitable…
June 2026
Corporate | Financial | Sustainability June 22, 2026
Symrise receives CDP’s top “A” rating for sustainable supplier engagement and Scope 3 transparency
– CDP recognizes supplier collaboration, climate action, and transparent data along the value chain
– Responsible sourcing supports customers in reaching Scope 3 targets and strengthens sustainable supply chains
May 2026
Corporate | Financial May 7, 2026
Annual General Meeting confirms dividend of €1.25 and approves all proposed resolutions
– CEO Dr Jean-Yves Parisot reports on solid growth and increased profitability in the 2025 financial year and progress in transformation
– Dividend of €1.25 per share approved
– Welcome to three new Supervisory Board members
April 2026
Corporate | Financial April 29, 2026
Symrise reports solid Q1 2026 sales results and reaffirms 2026 outlook
‒ Organic sales decline of 0.4% year-on-year, stronger than anticipated, with solid performance in Food & Beverage, Pet Food and Fragrance
‒ ONE SYM Transformation Program accelerating significant structural cost savings and efficiency gains to unlock organic growth opportunities through strategic reinvestment
‒ Full year 2026 outlook reaffirmed
March 2026
Corporate | Financial March 4, 2026
Symrise delivered solid organic sales growth and strong profitability improvement for 2025
— Organic sales growth of 2.8%; Group sales of €4,929 million
— Adjusted EBITDA margin of 21.9%, up 120 bps YoY
— Record adjusted Business Free Cash Flow (BFCF) of €780 million, or 15.8% BFCF margin, up 220 bps YoY
— Updated capital allocation priorities: announced inaugural €400 million share buyback and proposed 16th consecutive dividend increase to €1.25 per…
February 2026
Corporate | Financial | Investors February 9, 2026
American Authorities closing ongoing Antitrust Investigation against Symrise
The Department of Justice of the United States of America (“DoJ”) has informed Symrise by a letter dated February 5th, 2026, that it is closing its investigation against Symrise.
No unlawful practice of Symrise has been found. Symrise welcomes the decision by the DoJ. The company has always maintained that it did not participate in any unlawful agreements with…
Taste, Nutrition & Health | Scent & Care | Corporate | Financial | Sustainability February 3, 2026
CDP recognizes Symrise for sustainability results
– Symrise scores A- for Climate, A- for Water and B for Forest in 2025 CDP Ratings
– Result reflects high level of transparency and constant sustainability dedication
– Symrise demonstrates commitment to reducing environmental impacts
January 2026
Corporate | Financial January 12, 2026
Symrise AG Announces Inaugural Share Buy-back Program
— Supervisory Board authorizes repurchase of shares up to EUR 400 million
— The program will be active between 1 February and 31 October, 2026
Ad-hoc | Ad hoc January 12, 2026
Symrise AG resolves a share buy-back program in the amount of EUR 400 million
Symrise AG / Key word(s): Share Buyback Symrise AG resolves a share buy-back program in the amount of EUR 400 million 12-Jan-2026 / 20:07 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of
Ad-hoc | Ad hoc January 12, 2026
Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.
Symrise AG / Key word(s): Miscellaneous Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment. 12-Jan-2026 / 19:27 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the